MarketWatch
Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.
View original source — MarketWatch ↗
Related stories
Bloomberg
ScienceJun 16, 2026 · 1 min
SpaceX Stock Set for More Than 50% Jump in Just Three Sessions
Bloomberg
CNBC
WorldJun 19, 2026 · 1 min
Zealand Pharma stock suffered its two worst days on record. Here's what's next for the weight loss drugmaker
CNBC
Bloomberg
ScienceJun 18, 2026 · 1 min
SpaceX Shares Waver After Posting First Decline Since IPO
Bloomberg
MarketWatch
WorldJun 8, 2026 · 1 min
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
MarketWatch